Antrodia cinnamomea is a potentially effective complementary medicine for adjuvant therapy against breast cancer with bone metastasis: A case report

RATIONALE: Palbociclib (PAL) is a first-in-class selective inhibitor of the cyclin-dependent kinases 4 (CDK4) and CDK6 and is indicated for the treatment of hormone receptor (HR)-positive/human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer (MBC) in combination with fulv...

Descripción completa

Detalles Bibliográficos
Autores principales: Long, Huei, Hu, Chi-Tan, Prijatelj, Vesna, Weng, Ching-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
5750
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337546/
https://www.ncbi.nlm.nih.gov/pubmed/32629666
http://dx.doi.org/10.1097/MD.0000000000020808

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337546/
https://www.ncbi.nlm.nih.gov/pubmed/32629666
http://dx.doi.org/10.1097/MD.0000000000020808

Ejemplares similares